{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:19:42Z","timestamp":1773289182240,"version":"3.50.1"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T00:00:00Z","timestamp":1388016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083673","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T21:37:45Z","timestamp":1388093865000},"page":"e83673","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["ERBB2 in Cat Mammary Neoplasias Disclosed a Positive Correlation between RNA and Protein Low Expression Levels: A Model for erbB-2 Negative Human Breast Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Sara","family":"Santos","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia S.","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"Rui M. V.","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"Estela","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Ivo G.","family":"Gut","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"G\u00e4rtner","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Chaves","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejca.2003.11.031","article-title":"Spontaneous and genetically engineered animal models; use in preclinical cancer drug development","volume":"40","author":"K Hansen","year":"2004","journal-title":"Eur J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Zappulli V, De Zan G, Cardazzo B, Bargelloni L, Castagnaro M (2005) Feline mammary tumours in comparative oncology. J Dairy Res 72 Spec No: 98\u2013106.","DOI":"10.1017\/S0022029905001263"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/bcr2441","article-title":"The role of preclinical animal models in breast cancer drug development","volume":"11","author":"R Clarke","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-10-156","article-title":"Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions","volume":"10","author":"GP Burrai","year":"2010","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"R300","DOI":"10.1186\/bcr790","article-title":"First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases","volume":"6","author":"MD Perez-Alenza","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ, editor. Tumors in domestic animals. 4 ed.Iowa: Blackwell. pp. 575\u2013606.","DOI":"10.1002\/9780470376928.ch12"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00046339","article-title":"Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment","volume":"9","author":"EG MacEwen","year":"1990","journal-title":"Cancer Metastasis Rev"},{"key":"ref8","first-page":"709","article-title":"Prognostic factors in feline mammary carcinoma","volume":"70","author":"K Weijer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"ref9","unstructured":"Rutteman GR WS, MacEwen EG (2001) Tumors of the mammary gland In Small Animal Clinical Oncology; Withrow SJ MB, editor. Philadelphia: W.B. Saunders Company."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.89.10.4658","article-title":"Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor","volume":"89","author":"DM Ignar-Trowbridge","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","first-page":"854","article-title":"Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression","volume":"60","author":"H Buerger","year":"2000","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc1360","article-title":"The discovery of receptor tyrosine kinases: targets for cancer therapy","volume":"4","author":"A Gschwind","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","author":"RN Jorissen","year":"2003","journal-title":"Exp Cell Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/1078-0432.CCR-05-0976","article-title":"Somatic mutations of <italic>ERBB2<\/italic> kinase domain in gastric, colorectal, and breast carcinomas","volume":"12","author":"JW Lee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1024068525763","article-title":"HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites","volume":"79","author":"R Millikan","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/bcr982","article-title":"Common <italic>ERBB2<\/italic> polymorphisms and risk of breast cancer in a white British population: a case-control study","volume":"7","author":"PR Benusiglio","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref17","first-page":"1109","article-title":"The HER2 I655V polymorphism and risk of breast cancer in women &lt; age 40 years","volume":"12","author":"KG Montgomery","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(08)60784-8","article-title":"Biochemical and clinical implications of the ErbB\/HER signaling network of growth factor receptors","volume":"77","author":"LN Klapper","year":"2000","journal-title":"Adv Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2006.05.206","article-title":"Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo","volume":"346","author":"X Hu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/gcc.20558","article-title":"High-resolution genomic and expression analyses of copy number alterations in breast tumors","volume":"47","author":"PM Haverty","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/bcr2236","article-title":"The breast cancer somatic \u2018muta-ome\u2019: tackling the complexity","volume":"11","author":"AE Teschendorff","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"L Ding","year":"2008","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"16224","DOI":"10.1073\/pnas.0808041105","article-title":"Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers","volume":"105","author":"RJ Leary","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc1434","article-title":"Switching on kinases: oncogenic activation of BRAF and the PDGFR family","volume":"4","author":"NJ Dibb","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1158\/0008-5472.CAN-04-4235","article-title":"Somatic mutations of the HER2 kinase domain in lung adenocarcinomas","volume":"65","author":"H Shigematsu","year":"2005","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/2010-0454-RAR.1","article-title":"HER2: biology, detection, and clinical implications","volume":"135","author":"C Gutierrez","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jnci\/94.23.1807","article-title":"Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk","volume":"94","author":"A Hishida","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3835(01)00671-1","article-title":"Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States","volume":"173","author":"C Keshava","year":"2001","journal-title":"Cancer Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/sj.bjc.6603473","article-title":"HapMap-based study of the 17q21 <italic>ERBB2<\/italic> amplicon in susceptibility to breast cancer","volume":"95","author":"PR Benusiglio","year":"2006","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1158\/1078-0432.CCR-04-2208","article-title":"A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea","volume":"11","author":"W Han","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/1055-9965.EPI-08-1202","article-title":"Heritable variation of <italic>ERBB2<\/italic> and breast cancer risk","volume":"18","author":"JP Breyer","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref33","first-page":"MT57","article-title":"A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry","volume":"12","author":"P Potemski","year":"2006","journal-title":"Med Sci Monit"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1158\/1078-0432.CCR-04-1707","article-title":"Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy","volume":"11","author":"FJ Esteva","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref35","first-page":"4332","article-title":"HER-2\/neu amplification predicts poor survival in node-positive breast cancer","volume":"50","author":"A Borg","year":"1990","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/bjc.1997.283","article-title":"c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients&apos; overall and disease-free survival","volume":"75","author":"C Charpin","year":"1997","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.1523","article-title":"Comparative multi-methodological measurement of <italic>ERBB2<\/italic> status in breast cancer","volume":"202","author":"C Ginestier","year":"2004","journal-title":"J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/0008-5472.907.65.3","article-title":"Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer","volume":"65","author":"R De Maria","year":"2005","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.11273","article-title":"Prognostic value of ERBB family mRNA expression in breast carcinomas","volume":"106","author":"I Bieche","year":"2003","journal-title":"Int J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1593\/neo.08314","article-title":"A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas","volume":"10","author":"T Koletsa","year":"2008","journal-title":"Neoplasia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1354\/vp.42-1-30","article-title":"Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential","volume":"42","author":"F Millanta","year":"2005","journal-title":"Vet Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1476-5810.2005.00063.x","article-title":"Immunohistochemical detection of HER-2\/neu expression in spontaneous feline mammary tumours","volume":"3","author":"J Winston","year":"2005","journal-title":"Vet Comp Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-7-179","article-title":"Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study","volume":"7","author":"J Ordas","year":"2007","journal-title":"BMC Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms13032783","article-title":"Sequence Variants and Haplotype Analysis of Cat <italic>ERBB2<\/italic> Gene: A Survey on Spontaneous Cat Mammary Neoplastic and Non-Neoplastic Lesions","volume":"13","author":"S Santos","year":"2012","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"AC Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1471-2407-6-275","article-title":"Heterogeneity of mammary lesions represent molecular differences","volume":"6","author":"R Namba","year":"2006","journal-title":"BMC Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.4161\/cc.6.19.4914","article-title":"Breast tumor heterogeneity: cancer stem cells or clonal evolution?","volume":"6","author":"LL Campbell","year":"2007","journal-title":"Cell Cycle"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-006-9317-6","article-title":"Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases","volume":"102","author":"L Torres","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine","volume":"14","author":"JS Ross","year":"2009","journal-title":"Oncologist"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/modpathol.3880440","article-title":"HER-2\/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization","volume":"14","author":"TA Thomson","year":"2001","journal-title":"Mod Pathol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2003.12.014","article-title":"Molecular and functional characteristics of erbB2 in normal and cancer breast cells","volume":"209","author":"S Tommasi","year":"2004","journal-title":"Cancer Lett"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-004-2171-5","article-title":"HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses","volume":"89","author":"RC Millikan","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.canep.2011.01.007","article-title":"Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis","volume":"35","author":"IJ Dahabreh","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1056\/NEJMsa0708739","article-title":"Polygenes, risk prediction, and targeted prevention of breast cancer","volume":"358","author":"PD Pharoah","year":"2008","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(88)90184-5","article-title":"Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene","volume":"54","author":"WJ Muller","year":"1988","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"R357","DOI":"10.1186\/bcr1004","article-title":"A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer","volume":"7","author":"SE Nelson","year":"2005","journal-title":"Breast Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","article-title":"Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease","volume":"89","author":"CT Guy","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-6-114","article-title":"SNP-SNP interactions in breast cancer susceptibility","volume":"6","author":"VU Onay","year":"2006","journal-title":"BMC Cancer"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1097-2765(03)00048-0","article-title":"The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors","volume":"11","author":"TP Garrett","year":"2003","journal-title":"Mol Cell"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab","volume":"421","author":"HS Cho","year":"2003","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.crvi.2008.03.004","article-title":"Effect of deleterious nsSNP on the HER2 receptor based on stability and binding affinity with herceptin: a computational approach","volume":"331","author":"R Rajasekaran","year":"2008","journal-title":"C R Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1431927613001529","article-title":"Feline HER2 Protein Expression Levels and Gene Status in Feline Mammary Carcinoma: Optimization of Immunohistochemistry (IHC) and In Situ Hybridization (ISH) Techniques","volume":"19","author":"M Soares","year":"2013","journal-title":"Microsc Microanal"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcpa.2010.08.010","article-title":"An Immunohistochemical study of HER-2 expression in feline mammary tumours","volume":"144","author":"R Rasotto","year":"2011","journal-title":"J Comp Pathol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0959-8049(99)00264-6","article-title":"Assessment of HER2 status in breast cancer: why, when and how?","volume":"36","author":"M Dowsett","year":"2000","journal-title":"Eur J Cancer"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1006107016969","article-title":"The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer","volume":"52","author":"WJ Gullick","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/modpathol.3880007","article-title":"Determination of Her-2\/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization","volume":"13","author":"RE Jimenez","year":"2000","journal-title":"Mod Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/modpathol.3880372","article-title":"Defining a test for HER-2\/neu evaluation in breast cancer in the diagnostic setting","volume":"14","author":"WM Hanna","year":"2001","journal-title":"Mod Pathol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.47102\/annals-acadmedsg.V33N4p473","article-title":"The HercepTest and routine C-erbB2 immunohistochemistry in breast cancer: any difference?","volume":"33","author":"S Selvarajan","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1590\/S1676-24442004000100008","article-title":"HER-2\/neu immunoreactivity in invasive mammary carcinomas: a comparative study using monoclonal and polyclonal antibodies including the HercepTestTM","volume":"40","author":"AP Gouv\u00eaa","year":"2004","journal-title":"Jornal Brasileiro de Patologia e Medicina Laboratorial"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/clinchem\/45.8.1148","article-title":"Real-time reverse transcription-PCR assay for future management of <italic>ERBB2<\/italic>-based clinical applications","volume":"45","author":"I Bieche","year":"1999","journal-title":"Clin Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/j.1460-2075.1987.tb04797.x","article-title":"Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms","volume":"6","author":"MH Kraus","year":"1987","journal-title":"EMBO J"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-008-0010-9","article-title":"HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis","volume":"114","author":"W Tao","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000272953","article-title":"Real-time RT-PCR analysis for evaluating the Her2\/neu status in breast cancer","volume":"77","author":"M Cuadros","year":"2010","journal-title":"Pathobiology"},{"key":"ref74","first-page":"4744","article-title":"Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells","volume":"61","author":"MA Molina","year":"2001","journal-title":"Cancer Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnci\/djk134","article-title":"Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer","volume":"99","author":"M Scaltriti","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dna.1996.15.749","article-title":"Identification of a specific DNA region required for enhanced transcription of HER2\/neu in the MDA-MB453 breast cancer cell line","volume":"15","author":"SJ Miller","year":"1996","journal-title":"DNA Cell Biol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/0008-5472.CAN-07-1588","article-title":"Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations","volume":"68","author":"A Bremm","year":"2008","journal-title":"Cancer Res"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"e21022","DOI":"10.1371\/journal.pone.0021022","article-title":"Poly (A)<sup>+<\/sup> Transcriptome Assessment of <italic>ERBB2<\/italic>-Induced Alterations in Breast Cell Lines","volume":"6(6)","author":"DM Carraro","year":"2011","journal-title":"PLoS ONE"},{"key":"ref79","first-page":"1445","article-title":"Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome","volume":"63","author":"RL Camp","year":"2003","journal-title":"Cancer Res"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(00)00402-0","article-title":"The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker","volume":"37","author":"T Cooke","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/PAS.0b013e31819437f9","article-title":"Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol 33: 759\u2013767. cancer","volume":"33","author":"MZ Gilcrease","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tvjl.2011.01.011","article-title":"Sequence variation and mRNA expression of the TWIST1 gene in cats with mammary hyperplasia and neoplasia","volume":"191","author":"CS Baptista","year":"2012","journal-title":"Vet J"},{"key":"ref83","unstructured":"Misdorp W ER, Helm\u00e9n E, Lipscomb TP (1999) Histological Classification of Mammary Tumors of the Dog and Cat. Washington, USA: Armed Forces Institute of Pathology and World Health Organization."},{"key":"ref84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tvjl.2011.12.019","article-title":"Prognostic studies of canine and feline mammary tumours: the need for standardized procedures","volume":"193","author":"AJ Matos","year":"2012","journal-title":"Vet J"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jfms.2010.01.004","article-title":"Early detection, aggressive therapy: optimizing the management of feline mammary masses","volume":"12","author":"F Gimenez","year":"2010","journal-title":"J Feline Med Surg"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rvsc.2008.08.007","article-title":"An efficient protocol for genomic DNA extraction from formalin-fixed paraffin-embedded tissues","volume":"86","author":"S Santos","year":"2009","journal-title":"Res Vet Sci"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","article-title":"Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium","volume":"74","author":"CS Carlson","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"K Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1529\/biophysj.104.046003","article-title":"Molecular modelling of nearly full-length ErbB2 receptor","volume":"88","author":"P Bagossi","year":"2005","journal-title":"Biophys J"},{"key":"ref90","unstructured":"Schr\u00f6dinger L (2011) Maestro. 9.2 ed. New York, NY."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T04:44:25Z","timestamp":1716353065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083673"}},"subtitle":[],"editor":[{"given":"Rajeev","family":"Samant","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,12,26]]},"references-count":90,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083673","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,26]]}}}